Signal TrAnsduction Pathway Activity Analysis in OVarian cancER

Clinical trial NCT03458221 · RECRUITING

Trial details

NCT number: NCT03458221
Sponsor: Gynaecologisch Oncologisch Centrum Zuid
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer Signal Transduction Pathway Deregulation Therapy-Associated Cancer

Start date: 2023-01-31
Primary completion: 2026-10-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.